Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says
(MedPage Today) -- Tirzepatide (Zepbound) injections reduced sleep apnea severity among patients with obesity, regardless of positive airway pressure (PAP) use, according to topline data from two phase III trials.
In the SURMOUNT-OSA 1 study...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Eating Disorders & Weight Management | Heart | Obesity | Sleep Apnea | Sleep Disorders | Sleep Medicine | Study